Wang D, Olman MA, Stewart J Jr, Tipps R, Huang P, Sanders PW, Toline E, Prayson RA, Lee J, J Weil R, Palmer CA, Gillespie GY, Liu WM, Pieper RO, Guan JL, Gladson CL. 2011. Downregulation of FIP200 Induces Apoptosis of Glioblastoma Cells and Microvascular Endothelial Cells by Enhancing Pyk2 Activity. PLoS One. 6(5):e19629. PMID:21602932
Advani SJ, Markert JM, Sood RF, Samuel S, Gillespie GY, Shao MY, Roizman B, Weichselbaum RR. 2011. Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1. Gene Ther. 18(11):1098-102 PMID:21544094
Filippova N, Yang X, Wang Y, Gillespie GY, Langford C, King PH, Wheeler C, Nabors LB. 2011. The RNA-Binding Protein HuR Promotes Glioma Growth and Treatment Resistance. Mol Cancer Res. 9(5):648-59. PMID:21498545
Friedman GK, Gillespie GY. 2011. Cancer Stem Cells and Pediatric Solid Tumors. Cancers (Basel). 3(1):298-318. PMID:21394230
Sun M, Song L, Zhou T, Gillespie GY, Jope RS. 2011. The role of DDX3 in regulating Snail. Biochim Biophys Acta. 1813(3):438-47. PMID:21237216
Oliva CR, Nozell SE, Diers A, McClugage SG 3rd, Sarkaria JN, Markert JM, Darley-Usmar VM, Bailey SM, Gillespie GY, Landar A, Griguer CE. Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem. 285(51):39759-67 PMID: 20870728
Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C, Lamb LS Jr. Preclinical evaluation of ex vivo expanded/activated gammadelta T cells for immunotherapy of glioblastoma multiforme. J Neurooncol. 101(2):179-88. PMID: 20532954
Nabors LB, Fiveash JB, Markert JM, Kekan MS, Gillespie GY, Huang Z, Johnson MJ, Meleth S, Kuo H, Gladson CL, Fathallah-Shaykh HM.A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma. Arch Neurol. 67(3):313-9.PMID: 20212229
Friedman GK, Pressey JG, Reddy AT, Markert JM, Gillespie GY. 2009. Herpes simplex virus oncolytic therapy for pediatric malignancies. Mol Ther. 17(7):1125-35. PMID: 19367259
Kaliberova LN, Krendelchtchikova V, Harmon DK, Stockard CR, Petersen AS, Markert JM, Gillespie GY, Grizzle WE, Buchsbaum DJ, Kaliberov SA. 2009. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. Cancer Gene Ther. 16(10):794-805. PMID: 19363468
Pike MM, Stoops CN, Langford CP, Akella NS, Nabors LB, Gillespie GY. 2009. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med. 61(3):615-25. PMID: 19235262
Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, Lopez RD, Lamb LS Jr. 2009. Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma. Neuro Oncol. 11(4):357-67. PMID: 19211933
Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr, Gillespie GY. 2008. CD133 is a marker of bioenergetic stress in human glioma. PLoS One. 3(11):e3655. PMID: 18985161
Brantley EC, Nabors LB, Gillespie GY, Choi YH, Palmer CA, Harrison K, Roarty K, Benveniste EN.Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clin Cancer Res. 14(15):4694-704. PMID: 18676737
Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ. 2008. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5. Int J Radiat Oncol Biol Phys. 71(2):507-16. PMID: 18474311